rs180908546
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_024422.6(DSC2):c.136G>A(p.Glu46Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000978 in 1,605,112 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_024422.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DSC2 | NM_024422.6 | c.136G>A | p.Glu46Lys | missense_variant | 2/16 | ENST00000280904.11 | NP_077740.1 | |
DSC2 | NM_004949.5 | c.136G>A | p.Glu46Lys | missense_variant | 2/17 | NP_004940.1 | ||
DSC2 | NM_001406506.1 | c.-294G>A | 5_prime_UTR_variant | 2/16 | NP_001393435.1 | |||
DSC2 | NM_001406507.1 | c.-294G>A | 5_prime_UTR_variant | 2/17 | NP_001393436.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSC2 | ENST00000280904.11 | c.136G>A | p.Glu46Lys | missense_variant | 2/16 | 1 | NM_024422.6 | ENSP00000280904.6 | ||
DSC2 | ENST00000251081.8 | c.136G>A | p.Glu46Lys | missense_variant | 2/17 | 1 | ENSP00000251081.6 | |||
DSC2 | ENST00000648081.1 | c.-331G>A | 5_prime_UTR_variant | 2/17 | ENSP00000497441.1 | |||||
DSC2 | ENST00000682357.1 | c.-294G>A | 5_prime_UTR_variant | 2/16 | ENSP00000507826.1 |
Frequencies
GnomAD3 genomes AF: 0.0000857 AC: 13AN: 151714Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000955 AC: 24AN: 251332Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135846
GnomAD4 exome AF: 0.0000991 AC: 144AN: 1453280Hom.: 0 Cov.: 29 AF XY: 0.0000927 AC XY: 67AN XY: 723132
GnomAD4 genome AF: 0.0000856 AC: 13AN: 151832Hom.: 0 Cov.: 32 AF XY: 0.0000943 AC XY: 7AN XY: 74196
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Mar 20, 2024 | BP4 - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jul 19, 2024 | Identified in a patient with amyloidosis in published literature (PMID: 30847666); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 26768331, 30847666) - |
Cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Jan 10, 2023 | This missense variant replaces glutamic acid with lysine at codon 46 of the DSC2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with cardiovascular disorders in the literature. This variant has been identified in 25/282612 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Familial isolated arrhythmogenic right ventricular dysplasia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Jan 11, 2024 | This missense variant replaces glutamic acid with lysine at codon 46 of the DSC2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with cardiovascular disorders in the literature. This variant has been identified in 25/282612 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Arrhythmogenic right ventricular dysplasia 11 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2024 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 20, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at